Allianz’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594 Sell
70
-880
-93% -$5.86K ﹤0.01% 518
2026
Q1
$5.18K Buy
+950
New +$5.33K ﹤0.01% 458
2025
Q2
– Sell
-85
Closed -$677 – 441
2025
Q1
$677 Hold
85
– – ﹤0.01% 416
2024
Q4
$791 Sell
85
-607
-88% -$5.86K ﹤0.01% 430
2024
Q3
$6.35K Sell
692
-210
-23% -$1.74K ﹤0.01% 372
2024
Q2
$8.82K Hold
902
– – ﹤0.01% 440
2024
Q1
$13.6K Buy
+902
New +$16.4K ﹤0.01% 432

Other funds holding TDOC

Allianz's TDOC Position: Q2 2026 in Review

Allianz reduced its Teladoc Health (TDOC) stake by 93% in Q2 2026, selling an estimated $5.86K and leaving 70 shares worth $594. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Allianz first reported a position in TDOC in Q1 2024 and has held it in 7 quarters since. The position peaked at $13.6K in Q1 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Allianz held 70 shares of Teladoc Health worth $594 as of Q2 2026.
  • Allianz sold 880 Teladoc Health shares in Q2 2026, an estimated $5.86K.
  • Teladoc Health made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #518 holding.
  • Allianz first reported a position in Teladoc Health in Q1 2024 and has held it in 7 quarters since.
  • Allianz's Teladoc Health position peaked at $13.6K in Q1 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.